CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Evaluation of Ifosfamide Plus Doxorubicin & Filgrastim Versus Gemcitabine Plus Docetaxel & Filgrastim in the Treatment of Localized Poor Prognosis Soft Tissue Sarcoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00189137
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:03.469534+00:00
Published At: 2014-11-24T00:00:00+00:00
Record Updated At: 2015-12-07
Results Posted At: 2014-11-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Sarcoma, Soft Tissue"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-12-07"
protocolSection.identificationModule.nctId: "NCT00189137"
protocolSection.identificationModule.officialTitle: "Phase II Evaluation of Ifosfamide Plus Doxorubicin \u0026 Filgrastim Versus Gemcitabine Plus Docetaxel \u0026 Filgrastim in the Treatment of Localized Poor Prognosis Soft Tissue Sarcoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-11-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.